Stay updated on GLPG1690 in IPF Subjects: Clinical Trial
Sign up to get notified when there's something new on the GLPG1690 in IPF Subjects: Clinical Trial page.

Latest updates to the GLPG1690 in IPF Subjects: Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe ClinicalTrials.gov record for the GLPG1690 study in idiopathic pulmonary fibrosis is displayed, with study design, participant criteria, outcomes, locations, and study documents. The record indicates that the study was terminated and is no longer recruiting.SummaryDifference100%

- Check15 days agoChange DetectedThe site revision identifier in the footer changes from v3.7.2 to v3.8.0; the page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check21 days agoChange DetectedAn NIH-wide notice announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence.” The study record remains unavailable behind a 403 error.SummaryDifference1%

- Check29 days agoChange DetectedThe footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check35 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 on the page displaying a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now shows a 403 Forbidden error instead of the study record details, indicating the resource is inaccessible due to permission restrictions.SummaryDifference18%

Stay in the know with updates to GLPG1690 in IPF Subjects: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GLPG1690 in IPF Subjects: Clinical Trial page.